Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial.
Gabriele CrimiSergio LeonardiFrancesco CostaSara AriottiMatteo TebaldiSimone BiscagliaMarco ValgimigliPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2015)
In a large, contemporary, all-comers percutaneous coronary intervention population, CI-AKI was associated with an increased risk of all-cause death and the composite of death, stroke, or MI. While CI-AKI is more common in ACS than in stable CAD patients, its adjusted prognostic impact on the composite endpoint appears to be more pronounced in patients with stable CAD.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- cardiovascular events
- acute kidney injury
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- clinical trial
- magnetic resonance
- chronic kidney disease
- coronary artery bypass
- peritoneal dialysis
- magnetic resonance imaging
- high glucose
- type diabetes
- prognostic factors
- heart failure
- study protocol
- diabetic rats
- phase iii
- aortic stenosis
- computed tomography
- randomized controlled trial
- brain injury
- drug induced
- oxidative stress
- aortic valve